Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Minotti

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Current Cardiology Reports|April 17, 2019
Correction to: Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from TrastuzumabPierantonio Menna, Giorgio Minotti, Emanuela Salvatorelli
Chemotherapy|April 2, 2023
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and OpportunitiesEmanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna
Texas Heart Institute Journal|July 2, 2011
Managing cardiac risk factors in oncology clinical trialsApostolia-Maria Tsimberidou, Giorgio Minotti, Daniela Cardinale
Cardiovascular Toxicology|July 27, 2007
An introduction to the metabolic determinants of anthracycline cardiotoxicityPierantonio Menna, Stefania Recalcati, Gaetano Cairo, et al.
European Heart Journal. Cardiovascular Imaging|November 19, 2023
Temporal patterns of left ventricular systolic and diastolic metrics changes in adult patients with haematological malignancies treated with chimeric antigen receptor (CAR)-T cells: results from the CARdio-Tox prospective studyMassimiliano Camilli, Antonella Lombardo, Filippo Crea, et al.
Journal of Cardiovascular Pharmacology|October 10, 2023
Cost-Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in China: A New Pillar in Our Pockets, but at What Price?Massimiliano Camilli, Federico Ballacci, Federica Giordano, et al.
British Journal of Pharmacology|February 4, 2025
Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogenyGiorgio Minotti, Massimiliano Camilli, Emanuela Salvatorelli, et al.
Seminars in Oncology|November 27, 2019
Old and new directions of Cardio-OncologyMichael S Ewer, Joseph R Carver, Giorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2006
Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapiesEmanuela Salvatorelli, Pierantonio Menna, Luca Gianni, et al.
The Journal of Biological Chemistry|January 24, 2004
Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritinGianfranca Corna, Paolo Santambrogio, Giorgio Minotti, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Current Cardiology Reports|April 17, 2019
Correction to: Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from TrastuzumabPierantonio Menna, Giorgio Minotti, Emanuela Salvatorelli
Chemotherapy|April 2, 2023
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and OpportunitiesEmanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna
Texas Heart Institute Journal|July 2, 2011
Managing cardiac risk factors in oncology clinical trialsApostolia-Maria Tsimberidou, Giorgio Minotti, Daniela Cardinale
Cardiovascular Toxicology|July 27, 2007
An introduction to the metabolic determinants of anthracycline cardiotoxicityPierantonio Menna, Stefania Recalcati, Gaetano Cairo, et al.
European Heart Journal. Cardiovascular Imaging|November 19, 2023
Temporal patterns of left ventricular systolic and diastolic metrics changes in adult patients with haematological malignancies treated with chimeric antigen receptor (CAR)-T cells: results from the CARdio-Tox prospective studyMassimiliano Camilli, Antonella Lombardo, Filippo Crea, et al.
Journal of Cardiovascular Pharmacology|October 10, 2023
Cost-Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in China: A New Pillar in Our Pockets, but at What Price?Massimiliano Camilli, Federico Ballacci, Federica Giordano, et al.
British Journal of Pharmacology|February 4, 2025
Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogenyGiorgio Minotti, Massimiliano Camilli, Emanuela Salvatorelli, et al.
Seminars in Oncology|November 27, 2019
Old and new directions of Cardio-OncologyMichael S Ewer, Joseph R Carver, Giorgio Minotti
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2006
Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapiesEmanuela Salvatorelli, Pierantonio Menna, Luca Gianni, et al.
The Journal of Biological Chemistry|January 24, 2004
Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritinGianfranca Corna, Paolo Santambrogio, Giorgio Minotti, et al.
Pageof 13